Harald Anderson (Former)
1 – 10 of 95
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50–70 year old AML patients
(
- Contribution to journal › Article
- 2022
-
Mark
Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Clinical course and mortality by etiology of liver cirrhosis in Sweden : a population based, long-term follow-up study of 1317 patients
(
- Contribution to journal › Article
-
Mark
Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden : a population-based study
(
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer : 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
- 2018
-
Mark
Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosis
(
- Contribution to journal › Article
-
Mark
A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)
(
- Contribution to journal › Article
-
Mark
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer : The RASTEN trial
(
- Contribution to journal › Article
- 2017
-
Mark
Androgens in women after allogeneic hematopoietic cell transplantation : Impact of chronic GvHD and glucocorticoid therapy
(
- Contribution to journal › Article
-
Mark
Detection of glaucoma progression by perimetry and optic disc photography at different stages of the disease : Results from the Early Manifest Glaucoma Trial
(
- Contribution to journal › Article